Evidence map›Paper›PMID 34563033›Full record

ReviewGels (Basel, Switzerland)2021

Injectable Composite Systems Based on Microparticles in Hydrogels for Bioactive Cargo Controlled Delivery.

Henrique Carrêlo, Paula I P Soares, João Paulo Borges, Maria Teresa Cidade

Abstract readReview
In one paragraph

Review in Gels (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Stem cells and common biomaterials in dentistry: a review study.Journal of materials science. Materials in medicine · 2022
    Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Henrique CarrêloCENIMAT/i3N, Departamento de Ciência dos Materiais, NOVA School of Science and Technology, 2829-516 Caparica, Portugal.
Paula I P SoaresCENIMAT/i3N, Departamento de Ciência dos Materiais, NOVA School of Science and Technology, 2829-516 Caparica, Portugal.
João Paulo BorgesCENIMAT/i3N, Departamento de Ciência dos Materiais, NOVA School of Science and Technology, 2829-516 Caparica, Portugal.ORCID 0000-0002-3996-6545
Maria Teresa CidadeCENIMAT/i3N, Departamento de Ciência dos Materiais, NOVA School of Science and Technology, 2829-516 Caparica, Portugal.ORCID 0000-0001-8261-6754

Funding

Fundação para a Ciência e a Tecnologia POCI-01-0145-FEDER-007688 (Reference UID/CTM/50025)Fundação para a Ciência e a Tecnologia PTDC/CTMCTM/30623/2017Fundação para a Ciência e a Tecnologia SFRH/BD/144986/2019
6 · The paper itself

Abstract

Engineering drug delivery systems (DDS) aim to release bioactive cargo to a specific site within the human body safely and efficiently. Hydrogels have been used as delivery matrices in different studies due to their biocompatibility, biodegradability, and versatility in biomedical purposes. Microparticles have also been used as drug delivery systems for similar reasons. The combination of microparticles and hydrogels in a composite system has been the topic of many research works. These composite systems can be injected in loco as DDS. The hydrogel will serve as a barrier to protect the particles and retard the release of any bioactive cargo within the particles. Additionally, these systems allow different release profiles, where different loads can be released sequentially, thus allowing a synergistic treatment. The reported advantages from several studies of these systems can be of great use in biomedicine for the development of more effective DDS. This review will focus on in situ injectable microparticles in hydrogel composite DDS for biomedical purposes, where a compilation of different studies will be analysed and reported herein.

Indexed as

bioactive cargobiomedical applicationsdrug delivery systemshydrogelsmicroparticles

Identifiers

PMID34563033
PMCPMC8482158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.